Says labor markets remain well-balanced. Says will be exclusive partner of Nubank cards in U.S. Says company’s first agentic transaction occurred in Q3. Says small businesses remain a top priority.
Laura Kirk, Wellington Head of Private Capital Formation and board member of New York Road Runners, says Wellington's private investing arm is a roughly 10-year-old business within a 100-year-old ...
Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.
Alnylam Pharmaceuticals, Inc. is rated Hold due to high expectations, competitive threats, and revenue expansion. Learn more ...
Eli Lilly LLY reported 54% revenue growth in the third quarter as its diabetes and obesity drug tirzepatide ...
TipRanks on MSN
Eli Lilly price target raised to $950 from $900 at BofA
BofA raised the firm’s price target on Eli Lilly (LLY) to $950 from $900 and keeps a Buy rating on the shares after the company reported “strong” ...
Eli Lilly remains a top GARP opportunity, with Q3 results reinforcing its robust business growth and dominance in incretin ...
Recursion, Roche and Genentech unveiled the latest product of their nearly four-year artificial intelligence drug discovery collaboration. GSK ’s Blenrep was approved by the FDA for treatment of ...
The live event in Nashville, Tenn., featured 60-plus leaders, and also honored several companies with awards for supply chain excellence.
Before being discontinued, the P2X7 receptor blocker had cleared a master protocol study in chronic pain, though Eli Lilly ...
Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
Mounjaro generated sales of $6.5bn in Q3 2025, up 109% from the same period in 2024. Zepbound exhibited even higher growth – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback